My hands shook as I texted my husband. I felt unmoored in my body, as if I’d awoken in a different house than the one where I ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Actor and advocate Brooke Shields says learning how to embrace aging and prioritize preventive health in her 50s feels "like ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

The rash associated with shingles usually crusts over within seven to 10 days for people with a healthy immune system and ...

If the pain doesn't resolve with at-home treatment, gets worse or is accompanied ... Conditions like Lyme disease, measles, shingles or liver disease can all manifest in the eyes, and some severe ...

NanoViricides, Inc. (NYSE American.:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that it has now obtained a right of first refusal ...

EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

Multiple artists we spoke to unanimously agreed that the brand Viseart makes some of the best eye-shadow palettes on the ...

Viridian Therapeutics said Tuesday that an experimental treatment improved the signs and symptoms of thyroid eye disease — ...

The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...